Related Experiment Video

Updated: May 12, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look

Michael J Krowka1, Russell H Wiesner, Julie K Heimbach

  • 1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, United States. krowka@mayo.edu

Journal of Hepatology
|April 6, 2013
PubMed

Keywords:
AATDAlpha-1 antitrypsin deficiencyCOCOPDCTFDGFEV(1)FVCHCCHHHHTHPSHVMHepatic hydrothoraxHepatopulmonary syndromeHereditary hemorrhagic telangiectasiaILDIPFLTMELDMPAPOPTNOrgan Procurement and Transplant NetworkPBCPCWPPETPOPHPVRPortopulmonary hypertensionPulmonary nodulesREVEALRHHRVSRTRTIPSTPGTcMAAalpha-1 antitrypsin deficiencycardiac outputchronic obstructive pulmonary diseasecomputed tomographyfluorine-18 fluorodeoxyglucoseforced expiratory volume in one secondforced vital capacityhepatic hydrothoraxhepatic vascular malformationshepatocellular carcinomahepatopulmonary syndromehereditary hemorrhagic telangiectasiaidiopathic pulmonary fibrosisinterstitial lung diseaseliver transplantationmean pulmonary artery pressuremodel for end stage liver diseaseportopulmonary hypertensionpositron emission tomographyprimary biliary cirrhosispulmonary capillary wedge pressurepulmonary vascular resistancerefractory hepatic hydrothoraxregistry to evaluate early and long-term pulmonary artery hypertensionright ventriclescientific registry for transplant recipientstechnetium macroaggregated albumintransjugular intrahepatic portosystemic shunttranspulmonary gradient

More Related Videos

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP06:55

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP

Published on: February 14, 2022

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography09:23

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography

Published on: September 22, 2023

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...